Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Paul G. Ambrose, PharmD; MS; FIDSA
President
Institute for Clinical Pharmacodynamics
Poster(s):
(2530) Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dose Selection for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Community-Acquired Bacterial Pneumonia (CABP)
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2531) Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with
Staphylococcus aureus
Bacteremia (SAB)
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2532) Pharmacokinetic-Pharmacodynamic Analyses for Ceftobiprole Efficacy Based on Phase 3 Data from Patients with
Staphylococcus aureus
Bacteremia
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2568) Characterization of Sulopenem Pharmacokinetics-Pharmacodynamics Using a One-Compartment
In Vitro
Infection Model
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2569) Pharmacokinetic-Pharmacodynamic Evaluation of Sulopenem Using a Five-Day Hollow-Fiber
In Vitro
Infection Model
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
